STOK   $15.14  -0.59% Market Closed After Close 15.14 0.0

Stoke Therapeutics Inc
Total Cash 281.98M
totalCashPerShare 5.356
EBITDA -112.16M
Total Debt 5.83M
quickRatio 6.344
currentRatio 6.675
Total Revenue 15.16M
debtToEquity 2.401
Revenue/Share 0.316
ROA -0.25354
ROE -0.47847998
grossProfits
freeCashflow -21.53M
operatingCashflow -79.95M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -6.0736904
profitMargins 0.0
enterpriseValue 485.66M
forwardPE -5.767068
floatShares 31.77M
sharesOutstanding 52.65M
sharesShort 9.25M
sharesShortPriorMonth 9.82M
dateShortInterest
sharesPercentSharesOut 0.18%
heldPercentInsiders 0.05%
heldPercentInstitutions 1.17%
Short Ratio help_outline 24.63%
shortPercentOfFloat 0.26%
impliedSharesOutstanding
bookValue 4.64
Price To Book help_outline 3.09
earningsQuarterlyGrowth
netIncomeToCommon -103.57M
trailingEps -2.17%
forwardEps -2.49%
enterpriseToEbitda -4.33
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.53 3Q 2024
institutionsCount 160
lastUpdated Sept. 16, 2024, 6:49 p.m.